Table 1

Baseline characteristics of 100 patients assayed for urine bFGF and VEGF levels and entire CALGB 9480 population

Assayed patient subset (n = 100)Entire 9480 group (n = 390)
Median age, yr70 (63–76)70 (64–75)
Race, % white84%81%
Metastases
 % with bone9091
 % with lymph node2932
 % with lung66
 % with liver66
 % with measurable disease3936
Performance status
 0–185%88%
 215%12%
Laboratory values
 Median Hgb (g/dl)a13 (12–14)13 (11–14)
 Median PSA (ng/ml)a131 (42–321)128 (49–338)
 Median alkaline phosphatase (IU/l)a172 (106–271)164 (99–313)
 Median creatinine (mg/dl)a1.0 (1–1)1.0 (1–1)
Suramin dose
 Low36%34%
 Medium32%33%
 High32%33%
  • a Interquartile range.